The Bayer-partnered biopharmaceutical company has closed a further round of funding, taking its overall equity to almost $100m.
US-based biopharmaceutical company Kythera closed a $37.4m series D round of financing yesterday from a pool of investors including two law firms.
Foley Ventures, the corporate venturing unit of law firm Foley & Lardner intended to invest in the firm’s clients, and two partners of peer Latham & Watkins as well as the latter firm’s investment partnership, VP Company Investments 2008, invested in Kythera.
Filling out the series D investors were private equity fund Jafco, venture capital (VC) firms Versant…
